144 related articles for article (PubMed ID: 23338841)
21. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
[TBL] [Abstract][Full Text] [Related]
22. SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer.
Li J; Chen X; Zhu L; Lao Z; Zhou T; Zang L; Ge W; Jiang M; Xu J; Cao Y; Du S; Yu Y; Fan G; Wang H
Oncogene; 2021 Jul; 40(30):4884-4893. PubMed ID: 34163029
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
[TBL] [Abstract][Full Text] [Related]
24. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.
Zhang K; Waxman DJ
Mol Cancer; 2010 Dec; 9():319. PubMed ID: 21190562
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human pancreatic adenocarcinoma cell line with high metastatic potential in SCID mice.
Siedlar M; Stachura J; Szczepanik A; Popiela T; Mattei M; Vendetti S; Colizzi V; Zembala M
Invasion Metastasis; 1995; 15(1-2):60-9. PubMed ID: 7545654
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells.
Gaviraghi M; Tunici P; Valensin S; Rossi M; Giordano C; Magnoni L; Dandrea M; Montagna L; Ritelli R; Scarpa A; Bakker A
Biosci Rep; 2011 Feb; 31(1):45-55. PubMed ID: 20426768
[TBL] [Abstract][Full Text] [Related]
27. EpCAM-associated claudin-7 supports lymphatic spread and drug resistance in rat pancreatic cancer.
Thuma F; Zöller M
Int J Cancer; 2013 Aug; 133(4):855-66. PubMed ID: 23390083
[TBL] [Abstract][Full Text] [Related]
28. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
[TBL] [Abstract][Full Text] [Related]
29. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
30. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
Wang Z; Zhao K; Hackert T; Zöller M
Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
[TBL] [Abstract][Full Text] [Related]
31. CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.
Jung T; Gross W; Zöller M
J Biol Chem; 2011 May; 286(18):15862-74. PubMed ID: 21372142
[TBL] [Abstract][Full Text] [Related]
32. CD44v6 dependence of premetastatic niche preparation by exosomes.
Jung T; Castellana D; Klingbeil P; Cuesta Hernández I; Vitacolonna M; Orlicky DJ; Roffler SR; Brodt P; Zöller M
Neoplasia; 2009 Oct; 11(10):1093-105. PubMed ID: 19794968
[TBL] [Abstract][Full Text] [Related]
33. Generation of a human antibody that inhibits TSPAN8-mediated invasion of metastatic colorectal cancer cells.
Kim TK; Park CS; Jeoung MH; Lee WR; Go NK; Choi JR; Lee TS; Shim H; Lee S
Biochem Biophys Res Commun; 2015 Dec; 468(4):774-80. PubMed ID: 26562525
[TBL] [Abstract][Full Text] [Related]
34. [The role of exosomal tetraspanins and proteases in tumor progression].
Yunusova NV; Tugutova EA; Tamkovich SN; Kondakova IV
Biomed Khim; 2018 Mar; 64(2):123-133. PubMed ID: 29723143
[TBL] [Abstract][Full Text] [Related]
35. Murine and human pancreatic tumor exosome recovery in mouse serum: Diagnostic and prognostic potential and target cell delivery.
Erb U; Zhao K; Wang Z; Xiao L; Zöller M
Cancer Lett; 2017 Sep; 403():1-12. PubMed ID: 28619525
[TBL] [Abstract][Full Text] [Related]
36. Joint features and complementarities of Tspan8 and CD151 revealed in knockdown and knockout models.
Yue S; Zhao K; Erb U; Rana S; Zöller M
Biochem Soc Trans; 2017 Apr; 45(2):437-447. PubMed ID: 28408484
[TBL] [Abstract][Full Text] [Related]
37. Progress and potential of exosome analysis for early pancreatic cancer detection.
Erb U; Zöller M
Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
[TBL] [Abstract][Full Text] [Related]
38. [Establishment of subseries cell lines from tongue cancer single cell and detection of cancer stem cell markers].
Yao J; Xie J; Li J; Wei X; Yang Y; Chen H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):86-90. PubMed ID: 23484310
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Targeting Cancer-Initiating Cell Markers by Exosome miRNA: Efficacy and Functional Consequences Exemplified for claudin7 and EpCAM.
Kyuno D; Zhao K; Bauer N; Ryschich E; Zöller M
Transl Oncol; 2019 Feb; 12(2):191-199. PubMed ID: 30393102
[TBL] [Abstract][Full Text] [Related]
40. Exploiting Secreted Luciferases to Monitor Tumor Progression In Vivo.
Falcone L; Casucci M
Methods Mol Biol; 2016; 1393():105-11. PubMed ID: 27033220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
